Prices delayed by at least 15 minutes | Print


Redx Pharma PLC (REDX)

ORD 1P
Sell: 18p|Buy: 19p|Change: 0.20 (1.07%)

Open 

18.75p


Previous close 

18.75p


Trade high 

18.95p


Volume 

61,901


Year high 

37.90p


Year low 

17.00p


Dividend yield 

-


Market capitalisation 

£73.71 mn


P/E ratio 

-


ISIN 

GB00BSNB6S51


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Performance 27/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Redx Pharma PLC 0.00
More...

Company profile

Redx Pharma PLC is a United Kingdom-based biotechnology company focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases. Its product pipeline under development includes Porcupine Inhibitor, ROCK2 Selective Inhibitor, GI-targeted ROCK inhibitor, Pan-RAF Inhibitor, and others. The firm operates geographically in the UK and Ireland. Revenue is generated from; Scientific programmes and research collaboration, Research collaboration, and Research and preclinical development services.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
28/03/202403:49:4318.9513124.82
28/03/202402:42:4218.316,2502,973.75
28/03/202401:03:58183,000540.00
28/03/202409:50:3218.95101.90
28/03/202409:49:4218.95101.90

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.